Short Seller Accuses TransMedics Of 'Mafia Style' Scheme, Organ Transplant Company Says Short Seller Manipulating Market

1. Scorpion Capital alleges TransMedics engaged in fraudulent practices. 2. Short seller targets price at $0, highlighting high valuation metrics. 3. TransMedics disputes claims, citing inaccuracies and market manipulation motives. 4. Company faced declining sales, crucial for its already lofty valuation. 5. Scorpion plans to petition the FDA regarding the Organ Care System.